Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TNDM

+ Watchlist+ Portfolio

Tandem Diabetes Care, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$17.06
52-Week Range
$12.26 – $29.65
Market Cap
$1.19B
P/E (TTM)
—
EPS (TTM)
-0.70
Dividend Yield
0.00%
Advanced Metrics
Price/Book
8.80
PEG Ratio
—
Return on Equity
-36.73%
Return on Assets
-1.55%
Gross Margin
56.65%
Operating Margin
-2.35%
Profit Margin
-4.58%
Current Ratio
3.21
Debt/Equity
5.45
Total Debt
$736.54M
Free Cash Flow
$-65.56M
Revenue Growth
13.80%
Earnings Growth
—
Enterprise Value
$1.48B

Market Snapshot

About

Tandem Diabetes Care is a medical device company focused on developing and commercializing insulin delivery systems for people with diabetes. The company is best known for its t:slim X2 insulin pump with Control-IQ technology, which features automated insulin delivery and continuous glucose monitoring integration. Tandem offers innovative solutions designed to simplify diabetes management and improve patient outcomes.